Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular

E D Peterson1, E R DeLong, L H Muhlbaier

  • 1The Duke Outcomes Research and Assessment Group, Duke University Medical Center, Durham, North Carolina 27710, USA.

Insights

Comparing bypass surgery mortality risk models showed consistent hospital ratings but varied outlier identification. Risk-adjustment methods impact performance outlier designation, not overall hospital mortality rates.

Area of Science:

  • Cardiovascular surgery outcomes research
  • Health services research
  • Medical informatics

Background:

  • Cardiovascular "report cards" commonly use risk-adjusted surgical outcomes for comparisons.
  • The impact of different risk-adjustment methods on these comparative metrics is not well understood.

Purpose of the Study:

  • To evaluate the predictive accuracy of four clinical risk models for bypass surgery mortality.
  • To assess how hospital risk-adjusted surgical outcomes vary based on the applied risk-adjustment method.

Main Methods:

  • The Cooperative Cardiovascular Project's Pilot Revascularization Study analyzed 3,654 Medicare patients undergoing bypass surgery at 28 hospitals in Alabama and Iowa.
  • Compared the predictive accuracy of four bypass clinical risk models.
  • Assessed agreement in hospital-level risk-adjusted outcome performance ratings across different models.

Main Results:

  • All four risk models demonstrated similar predictive abilities (C-index: 0.71–0.74), though some overpredicted mortality in high-risk patients.
  • High correlation (0.93–0.97) was observed in hospital risk-adjusted mortality rates irrespective of the model used.
  • Limited agreement existed in identifying "performance outliers" based on the chosen risk-adjustment model and definition.

Conclusions:

  • Hospital risk-adjusted bypass surgery mortality ratings are consistent across different models, supporting their use for provider performance feedback.
  • The identification of performance outliers is sensitive to the specific benchmark and methodology employed.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...